Epidermal growth factor receptor expression and suramin cytotoxicity in vitro

This publication has 14 references indexed in Scilit:

• Suramin, an anti‐cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A
  FEBS Letters, 1989
• Prognostic significance of epidermal growth factor receptor in esophageal squamous cell carcinomas
  Cancer, 1989
• Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines
  Cancer Letters, 1988
• Blocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase Inhibitors
  Science, 1988
• Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: Establishment, characterization and response to cytotoxic treatment
  European Journal of Cancer and Clinical Oncology, 1988
• Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines.
  Molecular and Cellular Biology, 1988
• Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells
  Journal of Cellular Physiology, 1987
• EVALUATION OF A TETRAZOLIUM-BASED SEMIAUTOMATED COLORIMETRIC ASSAY - ASSESSMENT OF CHEMOSENSITIVITY TESTING
  1987
• Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors.
  Proceedings of the National Academy of Sciences, 1984
• Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies.
  Journal of Biological Chemistry, 1984